奥克股份(300082.SZ)：目前产品暂未涉及脑机领域

Core Viewpoint - The company has achieved EXCiPACT certification for its pharmaceutical-grade polyethylene glycol products and is currently serving over 400 pharmaceutical formulation enterprises, although its products do not yet extend to the brain-machine interface field [1] Group 1: Company Developments - The company has successfully passed EXCiPACT certification for its entire range of pharmaceutical-grade polyethylene glycol [1] - The company is currently providing services to more than 400 pharmaceutical formulation enterprises [1] - The company will disclose specific business expansion details in accordance with legal and regulatory standards if they meet the disclosure criteria [1] Group 2: Future Outlook - The company aims to continue leveraging innovative technologies and stable production capacity to serve its clients [1] - The company is focused on promoting the development of high-end application areas [1]